These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38205280)

  • 41. Qinzhizhudan formula dampens inflammation in microglia polarization of vascular dementia rats by blocking MyD88/NF-κB signaling pathway: Through integrating network pharmacology and experimental validation.
    Chen CA; Li CX; Zhang ZH; Xu WX; Liu SL; Ni WC; Wang XQ; Cheng FF; Wang QG
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116769. PubMed ID: 37400007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
    Li WH; Han JR; Ren PP; Xie Y; Jiang DY
    Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
    Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
    Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments.
    Fan L; Guo Y; Wu Q; Hu T; Chen X; Guo J; Liu Y; Lu Y; Lin M
    Evid Based Complement Alternat Med; 2023; 2023():6931644. PubMed ID: 36865745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hua-Feng-Dan alleviates LPS-induced neuroinflammation by inhibiting the TLR4/Myd88/NF-κB pathway: Through Integrating Network Pharmacology and Experimental Validation.
    Zhang Z; Pei Y; Zheng Y; Liu Y; Guo Y; He Y; Cheng F; Wang X
    Curr Pharm Des; 2024 Jun; ():. PubMed ID: 38910274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Qinlian hongqu decoction ameliorates hyperlipidemia via the IRE1-α/IKKB-β/NF-κb signaling pathway: Network pharmacology and experimental validation.
    Zhang Y; Guo Z; Wang J; Yue Y; Yang Y; Wen Y; Luo Y; Zhang X
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116856. PubMed ID: 37406747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of pulmonary infectious disease treatment with Mongolian medicine formulae based on data mining, network pharmacology and molecular docking.
    Zhou B; Qian Z; Li Q; Gao Y; Li M
    Chin Herb Med; 2022 Jul; 14(3):432-448. PubMed ID: 36118001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring potential pharmacological mechanisms of
    Zhang W; Zhou Q; Chen X; Zhao J; Shi J; Chen L
    Ann Med Surg (Lond); 2023 Jun; 85(6):2662-2676. PubMed ID: 37363456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects and mechanisms of Yi Qi Huo Xue Fang in cerebral ischemic stroke based on network pharmacology and experimental verification.
    Li J; Zhang T; Liu K; Hu G
    J Ethnopharmacol; 2023 Oct; 314():116611. PubMed ID: 37169318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential effects and mechanisms of hispidulin in the treatment of diabetic retinopathy based on network pharmacology.
    Chen Y; Sun J; Zhang Z; Liu X; Wang Q; Yu Y
    BMC Complement Med Ther; 2022 May; 22(1):141. PubMed ID: 35590353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Network Pharmacology-Based Investigation on the Mechanism of the JinGuanLan Formula in Treating Acne Vulgaris.
    Gholais NS; Shi C; Zhang J; Liao B; Albarmaqi RA; Tang X; Mi L
    Evid Based Complement Alternat Med; 2022; 2022():6944792. PubMed ID: 35873639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the potential mechanism of Fritiliariae Irrhosae Bulbus on ischemic stroke based on network pharmacology and experimental validation.
    Zijie W; Anan J; Hongmei X; Xiaofan Y; Shaoru Z; Xinyue Q
    Front Pharmacol; 2022; 13():1049586. PubMed ID: 36467049
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pharmacodynamic mechanism of Tibetan medicine Liurui Capsules on experimental autoimmune uveitis in rats based on network pharmacology and animal experiments].
    Bian M; Zhou Z; Zhu CS; Nie AZ; Li XP
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6687-6695. PubMed ID: 36604919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke.
    Ye J; Huang F; Zeng H; Xu X; Wu G; Tian S; Zhao J; Zhang W
    J Ethnopharmacol; 2023 Apr; 305():116092. PubMed ID: 36587875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring Active Compounds and Mechanisms of Angong Niuhuang Wan on Ischemic Stroke Based on Network Pharmacology and Molecular Docking.
    Zhang Y; Liu X; Long J; Cheng X; Wang X; Feng X
    Evid Based Complement Alternat Med; 2022; 2022():2443615. PubMed ID: 35388303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of
    Yang K; Zeng L; Ge A; Shi Y; Zhu X; Liu W; Ge J
    Oxid Med Cell Longev; 2020; 2020():6072380. PubMed ID: 33082911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of therapeutic mechanism of
    Zhang X; Chen Y; Li Z; Shang J; Yuan Z; Deng W; Luo Y; Han N; Yin P; Yin J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1051-1062. PubMed ID: 37488787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
    Wang J; Ge W; Peng X; Yuan L; He S; Fu X
    Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.